CPAP呼吸机联合氨溴索治疗ICU呼吸衰竭新生儿的效果及预后

Effect and prognosis of CPAP ventilator combined with ambroxol in the treatment of ICU respiratory failure neonates

目的探讨ICU呼吸衰竭新生儿实施CPAP呼吸机联合氨溴索治疗的效果及预后。方法选择本科室收治的70例ICU呼吸衰竭新生儿,根据治疗方式将其分为传统组和联合组,各35例。传统组实施常规治疗联合CPAP呼吸机治疗,联合组在传统组基础上加用氨溴索治疗。比较两组患儿的治疗效果。结果联合组患儿治疗总有效率明显高于传统组,并发症总发生率明显低于传统组,氧疗时间及住院时间明显短于传统组(P<0.05)。结论采用CPAP呼吸机联合氨溴索治疗ICU呼吸衰竭新生儿,可改善患儿治疗效果及预后,临床运用价值高。

Objective To investigate the effect and prognosis of CPAP ventilator combined with ambroxol in the treatment of ICU respiratory failure neonates. Methods Seventy cases of neonates with ICU respiratory failure enrolled in our department were selected and divided into traditional group（n =35） and combination group（n =35） according to their treatment methods. The traditional group was treated with conventional therapy combined with CPAP ventilator, and the combination group added ambroxol on the basis of the traditional group. The therapeutic effects of the two groups were compared. Results Compared with the traditional group, the total effective rate of treatment was significantly higher, the total incidence of complications was significantly lower, and the time of oxygen therapy and hospital stay were significantly shorter in the combination group（P 0.05）. Conclusion CPAP combined with ambroxol can improve the therapeutic effect and prognosis of neonates with ICU respiratory failure, with high clinical application value.